title: The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees.
abstract: OBJECTIVE
  During the last five decades drug and therapeutics committees (DTCs), have evolved from mainly hospital-based groups of experts in pharmacotherapy and drug logistics into an arena for healthcare professionals employing evidence-based methods of promoting rational drug use. The purpose of this study was to suggest a framework for analysing the structure and activities of DTCs.
  
  
  METHODS
  A literature search was carried out in the Medline, Cinahl and Web of Sciences databases for the period 1993-2012.
  
  
  RESULTS
  A total of 207 articles were included. Based on these articles a framework for the analysis of the DTCs based on the role of the DTC, target groups, budget perspective and type of economic decisions could be suggested.
  
  
  CONCLUSIONS
  In order to respond to future demands the DTCs will have to develop their skill in pharmacoeconomics. Their processes will have to be standardised and made more transparent in order to be better adapted to evidence-based decision-making. They will also have to embrace the possibilities created by electronic health records in both influencing the decisions of physicians, and in improving quality assurance programmes and longitudinal follow-up of drug therapy and outcomes. They will have to find new ways of interacting with the public and policy makers in order to get the resources needed for their work. Finally, they will have to handle the conflict among national, regional and local decision-making processes and the relationship between formularies and therapeutic guidelines.
authors: The NEPI foundation, Department of Health Analysis, Division of Medicine and Health, Linköping University, Linköping, Sweden. mikael.hoffmann@nepi.net
authors: Mikael
authors: M
authors: Hoffmann
mesh_terms: D003299:Cooperative Behavior; D003657:Decision Making; D019317:Evidence-Based Medicine; D006801:Humans; D010607:Pharmacy Service, Hospital / Q000458:organization & administration*; D010606:Pharmacy and Therapeutics Committee / Q000458:organization & administration*
references: Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000409
references: 17943742
references: Br J Clin Pharmacol. 1996 Nov;42(5):551-7
references: 8951185
references: Health Policy Plan. 2001 Mar;16(1):13-20
references: 11238425
references: Can J Cardiol. 2003 Feb;19(2):173-9
references: 12601443
references: Lakartidningen. 2004 Aug 5;101(32-33):2480-2, 2484
references: 15346621
references: Am J Health Syst Pharm. 2001 Dec 1;58(23):2251-66
references: 11763804
references: J Health Psychol. 2005 Jan;10(1):45-64
references: 15576500
references: Prev Med. 1986 Sep;15(5):475-91
references: 3774779
references: Pharm World Sci. 2010 Dec;32(6):767-75
references: 20820918
references: JAMA. 1980 May 16;243(19):1901-2
references: 7365970
references: Am J Health Syst Pharm. 2008 Jul 1;65(13):1272-83
references: 18589893
references: Eur J Clin Pharmacol. 1997;52(6):429-35
references: 9342577
references: Top Hosp Pharm Manage. 1994 Jan;13(4):47-53
references: 10130683
references: Med Care. 2005 Jul;43(7 Suppl):20-6
references: 16056005
references: Am J Health Syst Pharm. 2005 Feb 1;62(3):321-4
references: 15719594
references: An Med Interna. 1996 Oct;13(10):505-10
references: 9019201
references: Basic Clin Pharmacol Toxicol. 2010 Jul;107(1):531-59
references: 20590536
references: Pharm World Sci. 2007 Apr;29(2):90-6
references: 17187221
references: Br J Clin Pharmacol. 2012 Oct;74(4):640-3
references: 22420709
references: Am J Hosp Pharm. 1994 Oct 15;51(20):2593-8
references: 7847423
references: Am J Health Syst Pharm. 2005 Feb 15;62(4):378-90
references: 15745890
references: Pharmacoeconomics. 2000 Feb;17(2):175-85
references: 10947340
references: Hosp Formul. 1992 Oct;27 Suppl 2:2-3
references: 10122035
references: Am J Health Syst Pharm. 2005 Jan 15;62(2):189-95
references: 15700893
references: Public Health. 2006 May;120(5):451-61
references: 16513149
references: Pharm World Sci. 1999 Apr;21(2):74-9
references: 10380234
references: Am J Health Syst Pharm. 1999 Apr 1;56(7):622-8
references: 10423208
references: Am J Manag Care. 2002 Feb;8(2):161-9
references: 11858228
references: Br J Clin Pharmacol. 1999 Aug;48(2):239-46
references: 10417503
references: Expert Rev Pharmacoecon Outcomes Res. 2009 Feb;9(1):65-83
references: 19371180
references: Manag Care Interface. 2006 Jan;19(1):42-5
references: 16453995
references: Circulation. 2011 Sep 13;124(11):1290-310
references: 21844072
references: Clin Pharmacol Ther. 1962 Mar-Apr;3:235-8
references: 14474954
references: BMC Fam Pract. 2011 Aug 10;12:85
references: 21831317
references: Health Policy. 2003 Dec;66(3):295-303
references: 14637013
references: Clin Med (Lond). 2009 Oct;9(5):490-2
references: 19886115
references: Int J Clin Pharm. 2011 Jun;33(3):475-83
references: 21416393
references: Soc Sci Med. 2004 May;58(9):1757-66
references: 14990376
references: Can J Clin Pharmacol. 2009 Winter;16(1):e171-7
references: 19242000
references: Pharmacotherapy. 2005 Nov;25(11):1666-80
references: 16232030
references: Br J Clin Pharmacol. 1995 Jan;39(1):1-6
references: 7756093
references: Int J Health Care Qual Assur. 2007;20(2-3):161-78
references: 17585614
references: Eur J Clin Pharmacol. 1999 Oct;55(8):553-7
references: 10541772